Immunological battlefield in gastric cancer and role of immunotherapies

World J Gastroenterol. 2016 Jul 28;22(28):6373-84. doi: 10.3748/wjg.v22.i28.6373.

Abstract

Like the wars predating the First World War where human foot soldiers were deemed tools in the battlefield against an enemy, so too are the host immune cells of a patient battling a malignant gastric cancer. Indeed, the tumour microenvironment resembles a battlefield, where the patient's immune cells are the defence against invading tumour cells. However, the relationship between different immune components of the host response to cancer is more complex than an "us against them" model. Components of the immune system inadvertently work against the interests of the host and become pro-tumourigenic while other components soldier on against the common enemy - the tumour cell.

Keywords: Gastric cancer; Immune; Immune therapy; Immunology; Tumour microenvironment.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / immunology*
  • Adenocarcinoma / therapy
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Immunotherapy*
  • Stomach Neoplasms / immunology*
  • Stomach Neoplasms / therapy
  • Tumor Escape / immunology*
  • Tumor Microenvironment / immunology*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents